Skip to main content

Jurors wade through daunting evidence in high-stakes Meta trial about social media risks to children

SANTA FE, N.M. (AP) — A daunting stream of testimony and evidence has been presented in a New Mexico case that explores what the social media conglomerate Meta knew about the effects of its platforms on children.

State prosecutors allege Meta failed to disclose the risks that its platforms pose for children, including mental health problems and sexual exploitation. Meta’s attorneys have said the company has built-in protections for teenagers and weeds out harmful content but the company acknowledges some dangerous content gets past its safety nets.

Attorneys prepared for closing arguments to jurors next week after Meta on Friday closed out its showing of testimony and evidence and the trial completed its sixth week.

If jurors later find that Meta — which owns Instagram, Facebook and WhatsApp — violated New Mexico’s consumer protection laws, prosecutors say sanctions could add up to billions of dollars. Meta, however, says it would seek a different calculation.

The trial that started Feb. 9. is one of the first in a torrent of lawsuits against Meta and comes as school districts and legislators want more restrictions on the use of smartphones in classrooms.

A slated second phase of the trial, possibly in May before a judge with no jury, would determine whether Meta created a public nuisance with its social media platforms and should pay for public programs to fix matters.

Here’s what to know about the possible outcomes of the trial:

A reckoning in courts for social media platforms

Meta is confronting two counts of violating the New Mexico Unfair Trade Practices Act that protects consumers from deceptive or predatory business practices. An additional count was dropped Friday by the judge from a draft of jury instructions.

After closing arguments, jurors will weigh whether Meta knowingly misrepresented the risks on its platforms — by omission or active concealment at the least.

The case could sidestep immunity provisions that protect tech companies from liability for material posted on their social media platforms under Section 230, a 30-year-old provision of the U.S. Communications Decency Act, as well as a First Amendment shield.

In California, a jury already is sequestered in deliberations on whether social media companies should be liable for harms caused to children using their platforms, in one of three bellwether court cases that could set the course for thousands of similar lawsuits.

New Mexico’s case is built on a different foundation — including a state undercover investigation where agents created social media accounts posing as children to document sexual solicitations and the response from Meta.

The lawsuit, filed in 2023 by New Mexico Attorney General Raúl Torrez, also says the dangers of addiction to social media haven’t been fully disclosed or addressed by Meta. Meta hasn’t agreed that social media addiction exists, but executives acknowledge “problematic use” and say they want people to feel good about the time they spend on Meta’s platforms.

Among thousands of pages of documents, the New Mexico trial examines a raft of internal Meta correspondence and reports related to child safety. Jurors also heard testimony from Meta executives, platform engineers, whistleblowers who left the company, psychiatric experts and tech-safety consultants.

The jury also may be influenced by testimony from local public school educators who have struggled with disruptions linked to social media, including the exchange of violent and sexually explicit images, along with sextortion schemes targeting children in New Mexico.

Questions of unconscionable and willful conduct

One count of consumer protection violations alleges that Meta engaged in “unconscionable” trade practices that were grossly unfair.

In opening statements, prosecution attorney Donald Migliori emphasized accusations that Meta targeted social media engagement with children in an unconscionable way as a source of long-term profit while knowing children were at risk of sexual exploitation on social media. Meta disputes that argument by highlighting platform safety features and content filters for teenagers, who are seen by Meta as trendsetters with limited initial purchasing power to satisfy advertisers.

The jury would decide whether the conduct was “willful” and merits civil penalties of up to $5,000 per violation, and may help calculate the number of violations.

Torrez says those penalties could add up, given the number of people in New Mexico using Meta’s platforms. Meta, however, has asked to cap those sanctions at one penalty per misleading statement or fair-trade violation — and not the number of social media views or users.

Nuisance allegations to be decided by judge

State District Judge Bryan Biedscheid is overseeing both phases of the trial. He would decide nuisance allegations as the case advances — and whether the company is on the hook financially to repair damage.

Prosecutors have accused Meta of carelessly creating a marketplace and “breeding ground” for predators who target children for sexual exploitation. They allege Meta’s platforms also undermine the mental health of teenagers in a variety of ways — from sleep deprivation and depression to self-harm.

Attorneys for Meta accuse prosecutors of cherry-picking evidence as well as shoddy investigative work that may have made matters worse.

At trial, Meta executives described robust systems for detecting child sexual abuse material on its platforms and notifying law enforcement — but said the company also cautions users that its enforcement isn’t flawless.

“We believe it’s important to disclose the risks, but to do so in a consistent and rigorous way,” Instagram head Adam Mosseri said, describing a philosophy that extends to blog posts, service agreements and more.

In a video deposition played at trial, Meta CEO Mark Zuckerberg said that “safety is extremely important for the service and having it be something that people trust and want to use over time.” He said Meta in 2017 stopped linking business performance goals directly to the extended amount of time users spend on its platforms.

Torrez says he will request court-ordered relief to make Meta change the way it does business and remedy the harm to children from social media.

“We’re going to have meaningful investments in targeted strategic programming around how you use the internet and how you use social media in ways that are responsible and healthy,” he said on the opening day of the trial.

___

This version corrects that unconscionable trade practices are alleged in the third count of consumer protection violations, not the second and third counts.

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story